Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | gliotactin | 0.0122 | 0.0999 | 0.0999 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0122 | 0.0999 | 0.0999 |
Echinococcus multilocularis | acetylcholinesterase | 0.072 | 1 | 1 |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.0122 | 0.0999 | 0.0999 |
Loa Loa (eye worm) | hypothetical protein | 0.072 | 1 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.072 | 1 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.072 | 1 | 1 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0122 | 0.0999 | 0.5 |
Onchocerca volvulus | 0.0122 | 0.0999 | 0.5 | |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.0122 | 0.0999 | 0.0999 |
Echinococcus granulosus | acetylcholinesterase | 0.072 | 1 | 1 |
Onchocerca volvulus | 0.0122 | 0.0999 | 0.5 | |
Brugia malayi | Carboxylesterase family protein | 0.0122 | 0.0999 | 0.0999 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.0122 | 0.0999 | 0.0999 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0122 | 0.0999 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.0999 | 0.0999 |
Brugia malayi | Carboxylesterase family protein | 0.072 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0122 | 0.0999 | 0.0999 |
Loa Loa (eye worm) | carboxylesterase | 0.0122 | 0.0999 | 0.0999 |
Echinococcus granulosus | BC026374 protein S09 family | 0.0122 | 0.0999 | 0.0999 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.0122 | 0.0999 | 0.0999 |
Onchocerca volvulus | 0.0122 | 0.0999 | 0.5 | |
Echinococcus granulosus | neuroligin | 0.0122 | 0.0999 | 0.0999 |
Onchocerca volvulus | 0.0122 | 0.0999 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.0999 | 0.0999 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0122 | 0.0999 | 0.5 |
Echinococcus multilocularis | neuroligin | 0.0122 | 0.0999 | 0.0999 |
Brugia malayi | Carboxylesterase family protein | 0.0122 | 0.0999 | 0.0999 |
Echinococcus granulosus | acetylcholinesterase | 0.072 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.0999 | 0.0999 |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.0122 | 0.0999 | 0.0999 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0122 | 0.0999 | 0.0999 |
Echinococcus granulosus | carboxylesterase 5A | 0.072 | 1 | 1 |
Onchocerca volvulus | 0.0122 | 0.0999 | 0.5 | |
Brugia malayi | Carboxylesterase family protein | 0.0122 | 0.0999 | 0.0999 |
Schistosoma mansoni | acetylcholinesterase | 0.0122 | 0.0999 | 0.0999 |
Echinococcus multilocularis | carboxylesterase 5A | 0.072 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.072 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.072 | 1 | 1 |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.0122 | 0.0999 | 0.0999 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.0999 | 0.0999 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.0999 | 0.0999 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.0999 | 0.0999 |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.0122 | 0.0999 | 0.0999 |
Echinococcus multilocularis | acetylcholinesterase | 0.072 | 1 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0122 | 0.0999 | 0.0999 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.3346 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 0.0999 | 0.0999 |
Brugia malayi | hypothetical protein | 0.0122 | 0.0999 | 0.0999 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0122 | 0.0999 | 0.0999 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.631 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 4.1475 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 4.4668 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.